Proton Craniospinal Irradiation (CSI)
RadiationPatients will be enrolled to receive 30Gy (RBE) in 3Gy (RBE) or 25Gy (RBE) in 2.5Gy (RBE) fractions course of proton CSI.
NCT Number: NCT03520504
The purpose of this study is to find the safest and most effective dose for delivering proton beam to the space containing CSF, brain, and spinal cord, in treating leptomeningeal metastases. The researchers think that using proton beam radiation to treat the space containing CSF, brain, and spinal cord, instead of treating only the areas where the metastasized tumor cells are causing symptoms, would improve the treatment of this disease.
Looking for future studies?
Notify Me10 year and older
All sexes
Interventional
Phase 1
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be enrolled to receive 30Gy (RBE) in 3Gy (RBE) or 25Gy (RBE) in 2.5Gy (RBE) fractions course of proton CSI.
Time frame: 2 years
will be assessed by physician-graded CTCEAv4
Memorial Sloan Kettering Cancer Center
Other
A Phase Ib Study With Dose Expansion Cohort of Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03719768
Brain Diseases, Brain Neoplasms
Tampa, Florida, United States
View Trial DetailsNCT04343573
Central Nervous System Neoplasms, Leptomeningeal Metastases
Basking Ridge, New Jersey, United States
View Trial DetailsNCT05289908
Central Nervous System Neoplasms, Leptomeningeal Metastases
Changchun, Jilin, China
View Trial DetailsNCT02616393
Brain Diseases, Brain Metastases
Beverly Hills, California, United States
View Trial Details